WallStSmart

Cross Country Healthcare Inc (CCRN) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target

Cross Country Healthcare Inc stock (CCRN) is currently trading at $9.75. Cross Country Healthcare Inc PS ratio (Price-to-Sales) is 0.28. Analyst consensus price target for CCRN is $11.67. WallStSmart rates CCRN as Sell.

  • CCRN PE ratio analysis and historical PE chart
  • CCRN PS ratio (Price-to-Sales) history and trend
  • CCRN intrinsic value — DCF, Graham Number, EPV models
  • CCRN stock price prediction 2025 2026 2027 2028 2029 2030
  • CCRN fair value vs current price
  • CCRN insider transactions and insider buying
  • Is CCRN undervalued or overvalued?
  • Cross Country Healthcare Inc financial analysis — revenue, earnings, cash flow
  • CCRN Piotroski F-Score and Altman Z-Score
  • CCRN analyst price target and Smart Rating
CCRN

Cross Country Healthcare Inc

NASDAQHEALTHCARE
$9.75
$0.18 (1.88%)
52W$7.43
$15.30
Target$11.67+19.7%

📊 No data available

Try selecting a different time range

WallStSmart

Smart Analysis

Cross Country Healthcare Inc (CCRN) · 10 metrics scored

Smart Score

38
out of 100
Grade: F
Hold
Investment Rating

Category Performance

WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.

Investment Thesis

Strong fundamentals in price/sales, price/book, institutional own.. Concerns around peg ratio and return on equity. Mixed signals suggest waiting for clearer direction before acting.

Cross Country Healthcare Inc (CCRN) Key Strengths (3)

Avg Score: 10.0/10
Price/SalesValuation
0.2810/10

Paying less than $1 for every $1 of annual revenue

Price/BookValuation
0.9010/10

Trading below book value, meaning the market prices it less than net assets

Institutional Own.Quality
83.62%10/10

83.62% of shares held by major funds and institutions

Supporting Valuation Data

Price/Sales (TTM)
0.285
Undervalued
EV/Revenue
0.175
Undervalued
CCRN Target Price
$11.67
31% Upside

Cross Country Healthcare Inc (CCRN) Areas to Watch (7)

Avg Score: 1.0/10
Return on EquityProfitability
-25.60%0/10

Company is destroying shareholder value

Operating MarginProfitability
-0.62%0/10

Losing money on operations

Revenue GrowthGrowth
-23.60%0/10

Revenue declining -23.60%, a shrinking business

EPS GrowthGrowth
-78.50%0/10

Earnings declining -78.50%, profits shrinking

Profit MarginProfitability
-9.00%0/10

Company is losing money with a negative profit margin

PEG RatioValuation
7.982/10

Very expensive relative to growth, significant premium

Market CapQuality
$301M5/10

Small-cap company with higher risk but more growth potential

Supporting Valuation Data

Forward P/E
80
Expensive

Cross Country Healthcare Inc (CCRN) Detailed Analysis Report

Overall Assessment

This company scores 38/100 in our Smart Analysis, earning a F grade. Out of 10 metrics analyzed, 3 register as strengths (avg 10.0/10) while 7 fall into concern territory (avg 1.0/10). The category breakdown reveals uneven performance, with some areas requiring attention.

The Bull Case

The strongest argument centers on Price/Sales, Price/Book, Institutional Own.. Valuation metrics including Price/Sales (0.28), Price/Book (0.90) suggest the stock is attractively priced.

The Bear Case

The primary concerns are Return on Equity, Operating Margin, Revenue Growth. Some valuation metrics including PEG Ratio (7.98) suggest expensive pricing. Growth concerns include Revenue Growth at -23.60%, EPS Growth at -78.50%, which may limit upside. Profitability pressure is visible in Return on Equity at -25.60%, Operating Margin at -0.62%, Profit Margin at -9.00%.

Key Dynamics to Monitor

Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -25.60% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -23.60% needing to reaccelerate.

Risk Considerations

Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.

Bottom Line

Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.

Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.

CCRN Price-to-Sales(PS) Ratio Chart

Historical valuation based on market cap ÷ trailing 12-month revenue

CCRN's Price-to-Sales ratio of 0.28x trades 46% below its historical average of 0.53x (9th percentile). The current valuation is 74% below its historical high of 1.11x set in Jan 2007, and 24% above its historical low of 0.23x in Jun 2020. Over the past 12 months, the PS ratio has expanded from ~0.3x, reflecting growing market expectations outpacing revenue growth.

Compare CCRN with Competitors

Top MEDICAL CARE FACILITIES stocks by market cap

Compare any two stocks →

WallStSmart Analysis Synopsis

Data-driven financial summary for Cross Country Healthcare Inc (CCRN) · HEALTHCAREMEDICAL CARE FACILITIES

The Big Picture

Cross Country Healthcare Inc is in a turnaround phase, with management focused on restoring profitability. Revenue reached 1.1B with 24% decline year-over-year. The company is currently unprofitable, posting a -9.0% profit margin.

Key Findings

Cash Flow Positive

Generating 16M in free cash flow and 18M in operating cash flow. Earnings are translating into actual cash generation.

Low Leverage

Debt-to-equity ratio of 0.01 indicates a conservative balance sheet with 99M in cash.

Revenue Decline

Revenue contracted 24% YoY. Worth determining whether this is cyclical or structural.

Operating at a Loss

The company is unprofitable with a -9.0% profit margin. The path to breakeven will be the key catalyst.

What to Watch Next

Sector dynamics: monitor MEDICAL CARE FACILITIES industry trends, competitive moves, and regulatory changes that could impact Cross Country Healthcare Inc.

Bottom Line

Cross Country Healthcare Inc is in turnaround mode. The path to profitability remains the critical question. Speculative investors may see opportunity in the recovery story, but conservative investors should wait for consistent positive earnings before committing capital.

This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Insider Transactions

Loading insider activity...

About Cross Country Healthcare Inc(CCRN)

Exchange

NASDAQ

Sector

HEALTHCARE

Industry

MEDICAL CARE FACILITIES

Country

USA

Cross Country Healthcare, Inc. provides talent management and other consulting services for healthcare clients in the United States. The company is headquartered in Boca Raton, Florida.

Visit Cross Country Healthcare Inc (CCRN) Website
5201 CONGRESS AVENUE, BOCA RATON, FL, UNITED STATES, 33487